The conversion of cells from a normal phenotype to full malignancy apparently requires multiple genetic events. Efforts to reconstruct multistep tumorigenesis in cell culture have shown that two types of oncogenes (typified by HRAS and MYC) can cooperate to elicit complete transformation. Transformation of embryonic rodent cells by single oncogenes is reputed either not to occur or to require specialized circumstances. It has not been known how the large group of oncogenes that encode protein-tyrosine kinases might fit into this scheme. We now report that v-src, a prototype for the kinase oncogenes, can convert rat embryo fibroblasts to a fully transformed and tumorigenic phenotype when the gene is expressed vigorously. By contrast, v-src had no demonstrable effect on diploid human fibroblasts. Our results sustain the view that it is possible for at least some oncogenes to achieve a potency sufficient for unilateral tumorigenesis.
HRAS and MYC) can cooperate to elicit complete transformation. Transformation of embryonic rodent cells by single oncogenes is reputed either not to occur or to require specialized circumstances. It has not been known how the large group of oncogenes that encode protein-tyrosine kinases might fit into this scheme. We now report that v-src, a prototype for the kinase oncogenes, can convert rat embryo fibroblasts to a fully transformed and tumorigenic phenotype when the gene is expressed vigorously. By contrast, v-src had no demonstrable effect on diploid human fibroblasts. Our results sustain the view that it is possible for at least some oncogenes to achieve a potency sufficient for unilateral tumorigenesis.
Mutations, amplifications, and rearrangements of cellular protooncogenes that create potential oncogenes have been found in a wide variety of tumors (1, 2) . In an attempt to implicate these changes in tumorigenesis, various protooncogenes and oncogenes have been tested for their ability to transform primary cultures of embryonic rodent cells. None of the genes tested to date readily elicit full transformation, defined here as a combination of establishment, morphological changes, growth in semisolid medium, and tumorigenicity in experimental animals. Some oncogenes (typified by MYC) characteristically elicit established growth of cells that are only partially transformed (3) (4) (5) , whereas others (typified by RAS) transform cells but fail to sustain their growth unless the oncogene product is expressed in exceptional quantities and the cells are propagated in the absence of untransformed cells (6, 7) . It has been suggested that these distinctions might reflect different sites of action by the products of the oncogenes, with nuclear products serving primarily to establish growth and cytoplasmic products eliciting the remainder of the transformed phenotype (4). The suggestion has been reinforced by demonstrations that pairs of oncogenes encoding nuclear and cytoplasmic proteins can cooperate to elicit tumorigenic transformation (3, 4, 8) . It has not been clear how the large group of oncogenes that encode protein-tyrosine kinases might fit into the scheme of cooperative transformation. To address this question, we have evaluated the ability of the retroviral oncogene v-src to transform embyronic rat cells, in comparison to the activity of a mutant and transforming allele of HRAS known as EJ-RAS (9) and a normal human allele of the protooncogene MYC (10). colonies of cells were expanded and used to prepare cytoplasmic extracts. Extracts were normalized for protein content (14) and the v-src gene product and pp6Ov-src was precipitated with antibody from tumor-bearing rats as described (15, 16) . After incubation with [y-32P]ATP, the labeled immunoglobulin heavy chain was resolved by NaDodSO4/polyacrylamide gel electrophoresis and detected by autoradiography.
MATERIALS AND METHODS
Labeling and immunoprecipitation of pp64c-myc and p2lras were performed according to published methods (17, 18) . RESULTS
Transformation of REF Cells by v-src.
We transfected v-src alone (in the form of pZAS) or in combination with either MYC (pMLVLTRDMmyc) or a mutant allele of HRAS (pEJ-HSG) into cultured REFs (3). The cells were then propagated in the absence or presence of an independent selection. After 3 weeks, plates grown without selection were scored for the presence of foci of morphologically transformed cells. We found that transfection with pZAS, either alone or in combination with pEJ-HSG or pMLVLTRDMmyc, readily produced foci, whereas mock-transfected control plates had no foci ( Table 1 ). The plates that were cotransfected with pEJ-HSG or pMLVLTRDMmyc did not have more foci than plates transfected with pZAS alone (Table 1) . By contrast, the combination of EJ-RAS and MYC appeared more potent for transformation ( Table 1) .
The finding that v-src alone was sufficient to produce foci in the REF assay prompted us to determine whether the pZAS transfectants displayed other properties of transformed cells. Fig. 1 describes the morphology of several pZAS foci after expansion to confluence. The foci ranged in appearance from floridly transformed (round, clumped, and very refractile) to only slightly disorganized and refractile. All clones tested were capable of growth in soft agarose, and all clones elicited tumors when injected into nude mice ( Table   2 ). We also found that REF cells that were transfected with pZAS and subjected to selection for the linked marker gpt (rather than for morphological transformation) would grow in soft agarose and form tumors in nude mice. Some of these tumorigenic clones were morphologically transformed, but others were not (data not shown). Fig. 2 B and C) . Effect of Cotransfection of v-src with HRAS or MYC. Combining v-src with either MYC or EJ-RAS had only subtle consequences. In particular, all of the transformants obtained with a combination of pZAS and pMLVLTRDMmyc or pZAS and pEJ-HSG appeared floridly transformed by morphological criteria, in contrast to the diversity of foci produced by pZAS alone (data not shown). The cotransfectants, like pZAS transfectants, grew with high efficiency in soft agarose and produced tumors in nude mice ( Table 2 ). All cotransfectants tested grew as established lines.
Human Fibroblasts Are Not Transformed by v-src. The finding that v-src expression is sufficient to transform and establish primary rodent cells encouraged us to test the oncogene in human diploid skin fibroblasts. The pZAS vector was particularly useful in this experiment because it can be packaged as an amphotropic retrovirus and thus introduced into human cells with high efficiency (12) . We used skin fibroblasts from a patient with Lesch-Nyhan syndrome (GM0537) as recipient cells because these cells are deficient in the enzyme hypoxanthine phosphoribosyltransferase (HPRT) and will not grow in HAT medium unless an exogenous gpt gene (such as that found in pZAS) is provided as a substitute for the HPRT gene.
We produced amphotropic stocks of ZAS virus as described (12) and stocks of virus from the ZIPVGPT construct, which is identical to ZAS except that it lacks v-src. The ZAS virus produced foci and gpt-positive colonies readily on Rat-i cells. Infection of GM0537 cells with ZAS virus produced no foci, however. Of 14 HAT-resistant GM0537 clones picked after infection with the ZAS virus, none was capable of more doublings before senescence than any of several clones produced by infection with the ZIPVGPT virus. No ZAS virus-infected human clone produced any colonies in soft agarose or any tumors ( Table 2 ). The morphology of GM0537 cells expressing v-src was not significantly altered when compared with the parent cell (data not shown). Several clones produced more v-src kinase activity than did some of the pZAS-transfected REF clones that were fully transformed and established (Fig. 3) .
We also used the ZAS virus to infect skin fibroblast cultures GM2332 and GM0622, from individuals with tuberous sclerosis and neurofibromatosis, respectively. Individuals with these conditions are known to develop mesenchymal tumors with high frequency (24, 25) , suggesting that their fibroblasts might be more easily transformed than other human fibroblasts. Four GM2332 and five GM0622 gpt-positive clones were found to express pp60-src kinase activity and yet were not altered morphologically and were unable to grow in soft agarose or produce tumors in nude mice (data not shown). lower levels of expression. We presume that a threshold of expression must be exceeded if transformation is to be achieved (26) , and it is likely that the abundant expression utilized here is essential to full transformation, as reported for mutant alleles of RAS (6, 7) .
Our findings conform to the well-established ability of v-src to transform embryonic avian cells in culture (27) and to elicit tumors in chickens (27, 28 (30) and now differs from its cellular progenitor by the presence of both a genetic substitution and point mutations (31) . The mutations work in a combinatorial fashion to create (30) .
It has been suggested that tumorigenic transformation of embryonic rat cells requires the cooperation of two types of oncogenes-one encoding a protein that acts in the nucleus and the other encoding a cytoplasmic protein (3, 4, 8 The mechanism of this resistance has not been found, although karyotypic stability, efficient repair of DNA, and dominant trans-acting inhibitors of transformation have all been invoked as possible explanations (32) (33) (34) . Since the product of v-src elicits no permanent change in the genome of the cell, we presume that the resistance of human cells to transformation by the oncogene cannot be attributed to exceptional stability of the human genome. Instead, it seems possible that human cells lack the substrates whose phosphorylation accounts for the transformation of avian and rodent cells by v-src (or contain comparable substrates that are not recognized by the v-src product). The resistance could arise from the fact that the rodent and avian cells used for transformation by v-src originated from embryos, whereas the diploid human fibroblasts used here and in other studies with oncogenes were derived from differentiated tissue (generally skin). Further exploration of cellular resistance to the action of v-src may provide insight into the biochemical mechanisms of tumorigenesis.
